Hsbc Holdings PLC lowered its position in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 12.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 359,291 shares of the medical device company’s stock after selling 50,085 shares during the period. Hsbc Holdings PLC’s holdings in Cooper Companies were worth $29,459,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in COO. New York Life Investment Management LLC boosted its position in shares of Cooper Companies by 0.6% during the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after purchasing an additional 158 shares in the last quarter. Root Financial Partners LLC raised its holdings in Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares in the last quarter. Allworth Financial LP raised its holdings in Cooper Companies by 14.1% in the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after purchasing an additional 167 shares in the last quarter. Mesirow Financial Investment Management Inc. lifted its position in Cooper Companies by 1.3% during the third quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock valued at $961,000 after buying an additional 175 shares during the period. Finally, Blue Trust Inc. lifted its position in Cooper Companies by 13.9% during the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock valued at $124,000 after buying an additional 185 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on COO shares. Wells Fargo & Company reaffirmed a “sell” rating and issued a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Robert W. Baird lowered their price target on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Sunday. Finally, Mizuho set a $85.00 target price on shares of Cooper Companies and gave the company an “outperform” rating in a report on Thursday, June 4th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $81.31.
Cooper Companies Price Performance
Shares of NASDAQ:COO opened at $68.83 on Thursday. The business has a fifty day moving average price of $64.11 and a 200-day moving average price of $73.74. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The company has a market capitalization of $13.42 billion, a PE ratio of 58.33, a PEG ratio of 1.73 and a beta of 0.87. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83.
Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.
Cooper Companies Company Profile
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
See Also
- Five stocks we like better than Cooper Companies
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
